252 related articles for article (PubMed ID: 34199285)
41. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
Kupisiewicz K
Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
[TBL] [Abstract][Full Text] [Related]
42. [Extracellular vesicle-mediated drug resistance in multiple myeloma].
Yamamoto T; Yamamoto Y
Rinsho Ketsueki; 2023; 64(9):1092-1098. PubMed ID: 37899187
[TBL] [Abstract][Full Text] [Related]
43. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
Wang J; De Veirman K; Faict S; Frassanito MA; Ribatti D; Vacca A; Menu E
J Pathol; 2016 Jun; 239(2):162-73. PubMed ID: 26956697
[TBL] [Abstract][Full Text] [Related]
44. Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.
Ria R; Vacca A
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963513
[TBL] [Abstract][Full Text] [Related]
45. Exosome-Transmitted
Xu H; Han H; Song S; Yi N; Qian C; Qiu Y; Zhou W; Hong Y; Zhuang W; Li Z; Li B; Zhuang W
Clin Cancer Res; 2019 Mar; 25(6):1923-1935. PubMed ID: 30610101
[TBL] [Abstract][Full Text] [Related]
46. Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way.
Giannandrea D; Platonova N; Colombo M; Mazzola M; Citro V; Adami R; Maltoni F; Ancona S; Dolo V; Giusti I; Basile A; Pistocchi A; Cantone L; Bollati V; Casati L; Calzavara E; Turrini M; Lesma E; Chiaramonte R
Haematologica; 2022 Sep; 107(9):2183-2194. PubMed ID: 35263984
[TBL] [Abstract][Full Text] [Related]
47. Differential Therapeutic Effect of Extracellular Vesicles Derived by Bone Marrow and Adipose Mesenchymal Stem Cells on Wound Healing of Diabetic Ulcers and Correlation to Their Cargoes.
Pomatto M; Gai C; Negro F; Cedrino M; Grange C; Ceccotti E; Togliatto G; Collino F; Tapparo M; Figliolini F; Lopatina T; Brizzi MF; Camussi G
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917759
[TBL] [Abstract][Full Text] [Related]
48. The potential diagnostic power of extracellular vesicle analysis for multiple myeloma.
Canella A; Harshman SW; Radomska HS; Freitas MA; Pichiorri F
Expert Rev Mol Diagn; 2016; 16(3):277-84. PubMed ID: 26671731
[TBL] [Abstract][Full Text] [Related]
49. Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma.
Suzuki K; Nishiwaki K; Yano S
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33435539
[TBL] [Abstract][Full Text] [Related]
50. Extracellular vesicle-mediated cell-cell communication in haematological neoplasms.
Ohyashiki JH; Umezu T; Ohyashiki K
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158313
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-183-5p Increases with Age in Bone-Derived Extracellular Vesicles, Suppresses Bone Marrow Stromal (Stem) Cell Proliferation, and Induces Stem Cell Senescence.
Davis C; Dukes A; Drewry M; Helwa I; Johnson MH; Isales CM; Hill WD; Liu Y; Shi X; Fulzele S; Hamrick MW
Tissue Eng Part A; 2017 Nov; 23(21-22):1231-1240. PubMed ID: 28363268
[TBL] [Abstract][Full Text] [Related]
52. MicroRNAs-containing extracellular vesicles in bone remodeling: An emerging frontier.
Huang X; Xiong X; Liu J; Zhao Z; Cen X
Life Sci; 2020 Aug; 254():117809. PubMed ID: 32428598
[TBL] [Abstract][Full Text] [Related]
53. MiRNAs and piRNAs from bone marrow mesenchymal stem cell extracellular vesicles induce cell survival and inhibit cell differentiation of cord blood hematopoietic stem cells: a new insight in transplantation.
De Luca L; Trino S; Laurenzana I; Simeon V; Calice G; Raimondo S; Podestà M; Santodirocco M; Di Mauro L; La Rocca F; Caivano A; Morano A; Frassoni F; Cilloni D; Del Vecchio L; Musto P
Oncotarget; 2016 Feb; 7(6):6676-92. PubMed ID: 26760763
[TBL] [Abstract][Full Text] [Related]
54. The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38.
Bolzoni M; Toscani D; Costa F; Vicario E; Aversa F; Giuliani N
Immunol Lett; 2019 Jan; 205():65-70. PubMed ID: 29702149
[TBL] [Abstract][Full Text] [Related]
55. Characterization of Regulatory Extracellular Vesicles from Osteoclasts.
Huynh N; VonMoss L; Smith D; Rahman I; Felemban MF; Zuo J; Rody WJ; McHugh KP; Holliday LS
J Dent Res; 2016 Jun; 95(6):673-9. PubMed ID: 26908631
[TBL] [Abstract][Full Text] [Related]
56. Multiple Myeloma: New Insights and Therapeutic Approaches.
Anderson KC; Kyle RA; Dalton WS; Landowski T; Shain K; Jove R; Hazlehurst L; Berenson J
Hematology Am Soc Hematol Educ Program; 2000; ():147-165. PubMed ID: 11701540
[TBL] [Abstract][Full Text] [Related]
57. CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience.
Frerichs KA; Nagy NA; Lindenbergh PL; Bosman P; Marin Soto J; Broekmans M; Groen RWJ; Themeli M; Nieuwenhuis L; Stege C; Nijhof IS; Mutis T; Zweegman S; Lokhorst HM; van de Donk NWCJ
Expert Rev Clin Immunol; 2018 Mar; 14(3):197-206. PubMed ID: 29465271
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells.
Soley L; Falank C; Reagan MR
Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594
[TBL] [Abstract][Full Text] [Related]
59. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
60. Overcoming the Immunosuppressive Tumor Microenvironment in Multiple Myeloma.
Uckun FM
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
